News Daily News US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends Caitlin E. Cox November 17, 2020
News Conference News TCT 2020 While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry L.A. McKeown October 21, 2020
News Conference News TCT 2020 Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves Todd Neale October 17, 2020
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Daily News TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape Caitlin E. Cox September 14, 2020
News Daily News Should Guidelines Support TAVR for Low-Risk Patients? Two Views L.A. McKeown August 17, 2020
News Daily News ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes L.A. McKeown July 27, 2020
News Conference News EuroPCR 2020 Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR L.A. McKeown July 01, 2020
News Conference News TVT 2020 Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear Todd Neale June 25, 2020
News Conference News TVT 2020 Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years Michael O'Riordan June 22, 2020
News Conference News TVT 2020 Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes L.A. McKeown June 19, 2020
News Daily News Infective Endocarditis After TAVR Rare but Has Serious Consequences: SwissTAVI L.A. McKeown June 16, 2020
News Daily News SAVR After Failed TAVR: Rare and Risky, Registry Study Finds Yael L. Maxwell June 10, 2020
News Daily News Cardiogenic Shock Spells Poor Outcomes Despite Successful TAVR Todd Neale June 02, 2020
Presentation In-hospital Outcomes and Readmissions forValve-in-Valve TAVR vs Surgical Redo June 01, 2020
News Daily News TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data Michael O'Riordan June 01, 2020
News Conference News ACC 2020 PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients Yael L. Maxwell March 29, 2020